Dynatrace (DT)

NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-11-04

$43.70-6.58%

Close 2026-11-05 · 1-day change

Dynatrace (DT) Outlook: What's Priced In | QuarterlyIQ

Investment OutlookAs of Nov 4, 2026

What could strengthen or challenge Dynatrace’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-4.2%

+10% or more+5%0%−5%−10% or less

2.27 → 2.18 EPS · FY ending Mar 31, 2028 · 9 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 18 to 9; this is not the number of analysts revising. The ±10% axis is a display range.

Price, analyst earnings & P/E reference

The EPS and P/E reference is not available for DT yet.

Measure / period	Management expectations	Analyst expectations

Management figures unavailable.

Current consensus figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Annual recurring revenue (ARR) grows at least 18% YoY to $2.05B	Dynatrace grows revenue 19% yearly to $2.0B with ARR up 18% to $2.05B.	Under Pressure	ARR growth falls below 18% YoY in FY26 Q4	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-03-31 · fmp

FY2028 EPS$2.18

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Annual recurring revenue (ARR) grows at least 18% YoY to $2.05BPublished status: Under Pressure
Non-GAAP operating margin remains near 29%Direct metric needs a verified mapping
Total revenue grows at least 17% YoY to ~$2.33BRevenue: $579.918M

Next proof point

Next earnings date unavailable

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.7%Typical daily move · historical

Downside history

-34.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Dynatrace outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 31, 2026

What kind of bet this is

DT is a growth-oriented software business with improving cash generation, rather than a turnaround story. Its long-term thesis is intact, supported by recent execution, but volatile management and elevated risk keep the picture mixed.

What's priced into Dynatrace

DT is valued at a premium to peers, and the evidence labels that valuation as expensive. The current expectations gap is slightly negative, while the priced-in assessment is described as justified with low fragility. This suggests expectations are broadly supported, but the premium leaves room for disappointment if execution weakens.

What the fundamentals likely do

In the near term, management’s stated priorities are on track: revenue and annual recurring revenue have grown, operating income improved, and cash flow strengthened. Recent performance is neutral overall, and the reported miss risk is low, though peer misses and a deep miss in DT’s recent history remain cautions. A reversal of recently raised guidance would damage management credibility.

What Dynatrace hinges on

Over the next one to three years, the thesis depends on continued growth from cloud-native and AI workloads alongside improved profitability and cash generation. Near-term confidence also depends on management sustaining its raised guidance. Fed rate cuts or steadier results from large software peers could ease sector pressure, while weaker guidance would be a negative swing factor.

Bottom line

DT’s long-term thesis remains intact, with improving operating evidence balanced by an expensive valuation, elevated risk, and sensitivity to management credibility. The one-to-three-year view hinges on continued execution and sustained growth. Not investment advice.

Development preview · refreshed Nov 5, 2026Open Living FV detail

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$2.25	$2,669,416,602	20 / 27
2026-07-25	$2.26	$2,669,460,810	36 / 36
2026-07-26	$2.26	$2,669,460,810	36 / 36
2026-07-27	$2.25	$2,669,416,602	20 / 27
2026-07-28	$2.26	$2,669,460,810	36 / 36
2026-07-29	$2.25	$2,669,416,602	20 / 27
2026-07-30	$2.26	$2,669,460,810	36 / 36
2026-07-31	$2.26	$2,669,460,810	36 / 36
2026-08-01	$2.25	$2,669,416,602	20 / 27
2026-08-02	$2.26	$2,669,460,810	36 / 36
2026-08-03	$2.25	$2,669,417,557	20 / 27
2026-08-04	$2.25	$2,669,417,557	20 / 27
2026-08-05	$2.25	$2,669,417,557	20 / 27
2026-08-06	$2.25	$2,669,417,557	20 / 27
2026-08-07	$2.28	$2,661,812,291	20 / 27
2026-08-08	$2.29	$2,662,270,120	37 / 36
2026-08-09	$2.29	$2,662,270,120	37 / 36
2026-08-10	$2.28	$2,661,811,485	20 / 27
2026-08-11	$2.28	$2,661,811,485	20 / 27
2026-08-12	$2.29	$2,662,084,150	37 / 36
2026-08-13	$2.28	$2,661,811,485	20 / 27
2026-08-14	$2.28	$2,661,811,485	20 / 27
2026-08-15	$2.28	$2,661,811,485	20 / 27
2026-08-16	$2.28	$2,661,811,485	20 / 27
2026-08-17	$2.28	$2,661,811,485	20 / 27
2026-08-18	$2.28	$2,661,811,485	18 / 26
2026-08-19	$2.28	$2,661,811,485	18 / 25
2026-08-20	$2.27	$2,668,140,311	17 / 23
2026-08-21	$2.27	$2,668,140,311	17 / 22
2026-08-22	$2.27	$2,668,140,311	17 / 22
2026-08-23	$2.27	$2,668,140,311	17 / 22
2026-08-24	$2.27	$2,668,113,445	17 / 22
2026-08-25	$2.27	$2,668,113,445	17 / 22
2026-08-26	$2.27	$2,673,713,403	17 / 21
2026-08-27	$2.27	$2,673,713,403	17 / 21
2026-08-28	$2.27	$2,673,713,403	17 / 21
2026-08-29	$2.27	$2,673,713,403	17 / 21
2026-08-30	$2.27	$2,673,713,403	17 / 21
2026-08-31	$2.27	$2,673,713,403	17 / 21
2026-09-01	$2.27	$2,673,713,403	17 / 21
2026-09-02	$2.27	$2,673,713,403	17 / 21
2026-09-03	$2.28	$2,673,713,403	17 / 21
2026-09-04	$2.28	$2,673,713,403	17 / 21
2026-09-05	$2.28	$2,673,713,403	17 / 21
2026-09-06	$2.28	$2,673,713,403	17 / 21
2026-09-07	$2.28	$2,673,713,403	17 / 21
2026-09-08	$2.28	$2,673,713,403	17 / 21
2026-09-09	$2.28	$2,673,713,403	17 / 21
2026-09-10	$2.28	$2,673,713,403	17 / 21
2026-09-11	$2.28	$2,673,713,403	17 / 21
2026-09-12	$2.28	$2,672,831,178	17 / 21
2026-09-13	$2.28	$2,672,831,178	16 / 21
2026-09-14	$2.28	$2,672,831,178	16 / 21
2026-09-15	$2.28	$2,672,831,178	16 / 21
2026-09-16	$2.27	$2,672,160,261	17 / 22
2026-09-17	$2.27	$2,672,159,161	17 / 22
2026-09-18	$2.27	$2,672,159,161	17 / 22
2026-09-19	$2.27	$2,672,159,161	17 / 22
2026-09-20	$2.27	$2,673,162,405	17 / 22
2026-09-21	$2.27	$2,673,162,405	17 / 22
2026-09-22	$2.27	$2,673,163,326	17 / 22
2026-09-23	$2.27	$2,673,163,326	17 / 22
2026-09-24	$2.27	$2,673,163,326	17 / 22
2026-09-25	$2.27	$2,673,163,326	17 / 22
2026-09-26	$2.27	$2,673,163,326	17 / 22
2026-09-27	$2.27	$2,673,163,326	17 / 22
2026-09-28	$2.27	$2,673,163,326	17 / 22
2026-09-29	$2.27	$2,673,163,326	17 / 22
2026-09-30	$2.27	$2,673,163,326	17 / 22
2026-10-01	$2.27	$2,673,163,326	18 / 22
2026-10-02	$2.27	$2,674,653,313	18 / 22
2026-10-03	$2.27	$2,674,653,313	18 / 22
2026-10-04	$2.27	$2,674,653,313	18 / 22
2026-10-05	$2.27	$2,674,653,313	18 / 22
2026-10-06	$2.27	$2,674,653,314	18 / 22
2026-10-07	$2.27	$2,674,653,314	18 / 22
2026-10-08	$2.27	$2,674,653,314	18 / 22
2026-10-09	$2.28	$2,677,217,478	18 / 22
2026-10-10	$2.28	$2,677,217,478	18 / 22
2026-10-11	$2.28	$2,677,011,263	8 / 9
2026-10-12	$2.28	$2,677,011,260	8 / 9
2026-10-13	$2.28	$2,677,011,263	8 / 9
2026-10-14	$2.28	$2,677,011,263	8 / 9
2026-10-15	$2.28	$2,677,011,263	8 / 9
2026-10-16	$2.28	$2,677,011,263	8 / 9
2026-10-17	$2.28	$2,677,011,263	8 / 9
2026-10-18	$2.28	$2,677,011,263	8 / 9
2026-10-19	$2.28	$2,677,011,263	8 / 9
2026-10-20	$2.28	$2,677,011,263	8 / 9
2026-10-21	$2.28	$2,677,011,263	8 / 9
2026-10-22	$2.28	$2,677,009,527	8 / 9
2026-10-23	$2.28	$2,677,008,981	8 / 9
2026-10-24	$2.28	$2,678,920,820	9 / 11
2026-10-25	$2.28	$2,678,920,820	9 / 11
2026-10-26	$2.28	$2,678,920,820	9 / 11
2026-10-27	$2.28	$2,678,920,820	9 / 11
2026-10-28	$2.28	$2,678,903,283	9 / 11
2026-10-29	$2.28	$2,678,903,283	9 / 11
2026-10-30	$2.28	$2,678,903,283	9 / 11
2026-10-31	$2.28	$2,678,903,283	9 / 11
2026-11-01	$2.28	$2,678,903,283	9 / 11
2026-11-02	$2.28	$2,678,903,283	9 / 10
2026-11-03	$2.28	$2,678,903,283	9 / 10
2026-11-04	$2.18	$2,694,939,699	9 / 13

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-06-01	26	12	0
2026-07-01	26	11	0
2026-08-01	27	11	0
2026-09-01	28	11	1
2026-10-01	28	9	1
2026-11-01	28	8	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 28 Buy / Strong Buy · 8 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades18 maintains

Recent actions · Oct 6–Nov 4 · 18 recorded

What could strengthen or challenge Dynatrace’s outlook?

Price, analyst earnings & P/E reference

What the Thesis Depends On

Incoming Evidence

Expectations trend

Outlook in Brief

What's improving

Still unresolved / key risks

Next proof point

Historical risk context

Dynatrace outlook in detail

What kind of bet this is

What's priced into Dynatrace

What the fundamentals likely do

What Dynatrace hinges on

Bottom line

Analyst view

Price-target changes

Bottom line